Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 65

How mannitol affects propofol levels during brain surgery

Official title: Propofol Level at TCI During Mannitol

Run by Cukurova University · NCT06884657 · Data updated 2026-11-12

This study will test whether giving mannitol changes blood and urine propofol levels in adults having supratentorial tumor or pituitary surgery under total intravenous anesthesia.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment40 (estimated)
SponsorCukurova University
Academic / other
Locations1 site (Çukurova, Adana)
StatusRecruiting
StartedMarch 20, 2025
Main results expectedOctober 20, 2025
Study endsOctober 30, 2025
Registry record updatedSeptember 2, 2025
Trial IDNCT06884657 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults (≥18) with ASA II who are scheduled for supratentorial tumor or pituitary surgery and who are eligible for total intravenous anesthesia and mannitol where indicated.

Probably not a fit

Patients with ASA III or higher, chronic kidney failure, sepsis, or multiorgan failure would not be expected to benefit from or be eligible for this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Forty adults (20 per group) undergoing supratentorial tumor or pituitary surgery at Çukurova University will be enrolled. All patients will receive target-controlled infusions set to propofol 4 µg/dl and remifentanil 2–4 µg/dl; the mannitol group will receive 2.5 ml/kg (0.5 g/kg) mannitol 20 minutes after induction over 10 minutes while the control group receives 2.5 ml/kg isotonic saline over 10 minutes. Blood and urine samples will be collected to measure propofol concentrations, and invasive hemodynamic monitoring plus bispectral index (BIS) will be recorded for all participants. Key exclusions include chronic kidney failure, sepsis, multiorgan failure, or ASA class III and above.

Why it matters

Potential benefit: If successful, results could help anesthesiologists adjust propofol dosing when mannitol is used, reducing the risk of over- or under-sedation.

How similar studies have gone: There is limited prior research directly measuring how mannitol affects propofol concentrations, so this approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* American Society of Anesthesiologist (ASA) II participants
* supratentorial tumor surgery
* eligible for mannitol use
* eligible for Total intravenous anesthesia (TIVA)

Exclusion Criteria:

* American Society of Anesthesiologist (ASA) III and upper
* Chronic kidney failure
* sepsis
* multiorgan failure

Where it's running

  • Çukurova University
    Çukurova, Adana, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.